Publications by authors named "Daoud Al-Badriyeh"

Claim this Profile
T
The next decade of cardiovascular disease burden in Qatar, a gulf cooperation council country: Projections from 2024 to 2033.
Dina Abushanab, Daoud Al-Badriyeh, Rawan F Al Froukh, Rasha Kaddoura, Mohammed Abdelaal

Curr Probl Cardiol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating the economic impact of clinical pharmacist interventions in the women's health setting in Qatar.
Daoud Al-Badriyeh, Shimaa Aboelbaha, Nurhan ElShafey, Moza Al Hail, Wessam El-Kassem

Int J Clin Pharm· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of a multidisciplinary team-delivered deprescribing intervention for patients with chronic kidney disease: a protocol for a randomised controlled trial.
Amani Zidan, Abdullah Hamad, Rania Ibrahim, Mohamed El-Kadi, Hasan El-Malki, Daoud Al-Badriyeh

J Pharm Policy Pract· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prescribing trends of cardioprotective medications among patients with diabetes and ASCVD in primary care setting in Qatar.
Myriam Jaam, Ahmed Awaisu, Daoud Al-Badriyeh, Amani Zidan, Rana Abu Samaha

J Pharm Policy Pract· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extent and Mitigation of Financial Toxicity of Immune Checkpoint Inhibitors for the Treatment of Advanced Hepatocellular Carcinoma.
Nabil E Omar, Hazem Elewa, Kareem A El-Fass, Dario Trapani, Said Dermime, Daoud Al-Badriyeh

Cancer Control· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unraveling the future productivity burden of cardiovascular disease in Qatar: Investigating the modifiable risk factors control in type 2 diabetes.
Dina Abushanab, Daoud Al-Badriyeh, Danny Liew, Zanfina Ademi

Am J Prev Cardiol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exposure to High-Dose Liraglutide in a Pregnant Woman With Obesity.
Dina Abushanab, Haseebur Rahman Mohammed, Palli Valappila Abdul Rouf, Binny Thomas, Daoud Al-Badriyeh

O G Open· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of daratumumab for the treatment of refractory/relapsed multiple myeloma. A systematic review of meta-analyses.
Diala Alhaj Moustafa, Laila Shafei, Ruba Sulaiman, Mohamed A Yassin, Dina Abushanab, Daoud Al-Badriyeh

J Oncol Pharm Pract· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dihydropyrimidine Dehydrogenase Deficiency (DPYD) Genotyping-Guided Fluoropyrimidine-Based Adjuvant Chemotherapy for Breast Cancer. A Cost-Effectiveness Analysis.
Dina Abushanab, Shaban Mohamed, Rania Abdel-Latif, Diala Alhaj Moustafa, Wafa Marridi, Daoud Al-Badriyeh

Clin Drug Investig· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness analysis of genotype-guided optimization of major depression treatment in Qatar.
Dina Abushanab, Shaban Mohammed, Rania Abdel-Latif, Wadha Al-Muftah, Said I Ismail, Daoud Al-Badriyeh

J Pharm Policy Pract· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Reduction of the Productivity Burden of Cardiovascular Disease by Improving the Risk Factor Control Among Australians with Type 2 Diabetes: A 10-Year Dynamic Analysis.
Dina Abushanab, Daoud Al-Badriyeh, Clara Marquina, Jedidiah I Morton, Melanie Lloyd

Eur J Prev Cardiol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics of the clinical pharmacist interventions at the National Center for Cancer Care and Research Hospital in Qatar.
Sara Al Dali, Daoud Al-Badriyeh, Amaal Gulied, Anas Hamad, Moza Al Hail

J Oncol Pharm Pract· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Direct oral anticoagulants versus low-molecular-weight heparin in patients with cancer-associated venous thrombosis: a cost-effectiveness analysis.
Wei Kang, Kuan Peng, Vincent K C Yan, Daoud Al-Badriyeh, Shing Fung Lee

J Pharm Policy Pract· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of selinexor for patients with relapsed and refractory multiple myeloma: A meta-analysis.
Laila Shafei, Shaima Bashir, Esther W Chan, Dina Abushanab, Anas Hamad, Daoud Al-Badriyeh

Curr Probl Cancer· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
QPGx-CARES: Qatar pharmacogenetics clinical applications and research enhancement strategies.
Rania Abdel-Latif, Radja Badji, Shaban Mohammed, Wadha Al-Muftah, Hamdi Mbarek, Daoud Al-Badriyeh

Clin Transl Sci· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of l-glutamine versus crizanlizumab for adults with sickle cell disease: model focused on reducing pain episode costs from Qatar's healthcare perspective.
Ahmad M Adel, Dina Abushanab, Daoud Al-Badriyeh, Anas Hamad, Awni Alshurafa

SAGE Open Med· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A cost-effectiveness analysis for high versus standard (low) dose caffeine for the treatment of apnea in neonatal intensive care unit.
Eilan Al-Hersh, Dina Abushanab, Fouad AbouNahia, Daniel Rainkie, Moza Al Hail, Daoud Al-Badriyeh

J Pharm Policy Pract· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Beta-blocker therapy in heart failure with preserved ejection fraction (B-HFpEF): A systematic review and meta-analysis.
Rasha Kaddoura, Vichithranie Madurasinghe, Ammar Chapra, Dina Abushanab, Daoud Al-Badriyeh

Curr Probl Cardiol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost‑effectiveness of add‑on dapagliflozin for heart failure with reduced ejection fraction patients without diabetes.
Dina Abushanab, Salma Chbib, Rasha Kaddoura, Moza Al Hail, Palli Valappila Abdul Rouf, Daoud Al-Badriyeh

J Med Econ· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The cost associated with the development of the antimicrobial stewardship program in the adult general medicine setting in Qatar.
Dina Abushanab, Wafa Al-Marridi, Moza Al Hail, Palli Valappila Abdul Rouf, Wessam ElKassem, Daoud Al-Badriyeh

J Pharm Policy Pract· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Societal health and economic burden of cardiovascular diseases in the population with type 2 diabetes in Qatar. A 10-year forecasting model.
Dina Abushanab, Daoud Al-Badriyeh, Clara Marquina, Danny Liew, Manal Al-Zaidan

Diabetes Obes Metab· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Letter to Editor on Fawad et al. Comment on "Cost-Effectiveness Analysis of Ibuprofen versus Indomethacin or Paracetamol for the Treatment of Patent Ductus Arteriosus in Preterm Neonates" by Al-Shaibi et al.
Samaher Al-Shaibi, Dina Abushanab, Fouad Abounahia, Ahmed Awaisu, Daoud Al-Badriyeh

Curr Probl Cardiol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical pharmacists' interventions for preventing adverse events in critically ill neonates in Qatar: an economic impact analysis.
Ola Yakti, Daoud Al-Badriyeh, Mohammed Rijims, Mohammed Abdelaal, Omar Alsoukhni

J Pharm Policy Pract· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics of the clinical pharmacists' interventions at the main general tertiary care hospital in Qatar.
Lina Naseralallah, Daoud Al-Badriyeh, Mounir Atchan, Palli Valappila Abdul Rouf, Moza Al Hail

Qatar Med J· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of a risk prediction model for COVID-19: the PERIL prospective cohort study.
Shahd A Mohammedain, Saif Badran, AbdelNaser Y Elzouki, Halla Salim, Ayesha Chalaby, Daoud Al-Badriyeh

Future Virol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis